Accuray Incorporated (FRA:XEJ)

Market Cap	105.57M
Revenue (ttm)	384.30M
Net Income (ttm)	-16.46M
Shares Out	n/a
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,062
Average Volume	3,753
Open	0.8850
Previous Close	0.8850
Day's Range	0.8850 - 0.9350
52-Week Range	0.8100 - 2.5400
Beta	n/a
RSI	40.77
Earnings Date	Jan 28, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1990
• Employees: 990
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XEJ

Financial Performance

In 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD